Genprex is Pioneering the Use of Non-Viral Vectors in Gene Therapy December 17, 2019Kalyn DabbsBlog Posts Genprex is once again leading the way in gene therapy and raising the standard in cancer treatment based upon its unique, proprietary technology platform that includes its non-viral vector nanoparticle delivery system. Read More